[Federal Register Volume 67, Number 54 (Wednesday, March 20, 2002)]
[Notices]
[Page 12996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-6681]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee/Vaccine Supply Conference 
Call

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal Advisory Committee 
meeting.

    Name: National Vaccine Advisory Committee (NVAC) Vaccine Supply 
Conference Call.
    Time and Date: 11 a.m.-1 p.m., April 1, 2002.
    Place: Audio Conference Call.
    Status: This meeting is open to the public, telephone lines are 
limited. The public can join the meeting by Audio Conference Call by 
calling (888) 398-1687 and providing the following information:
    Pass code: Peter.
    Leaders Name: Dr. Georges Peter.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: To discuss recommendations from the 
NVAC Workshop on Strengthening the Vaccine Supply.
    Agenda items are subject to change as priorities dictate.
    Public comments will be permitted at the end of the NVAC meeting 
on April 1, 2002.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4770 Buford Highway, M/S K-77, 
Atlanta, Georgia 30341, telephone (770)488-2040.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 12, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-6681 Filed 3-19-02; 8:45 am]
BILLING CODE 4163-18-P